Innate Pharma (IPHA) Non-Current Assets (2017 - 2026)
Innate Pharma (IPHA) reported Non-Current Assets of $17.58 million for the quarter ended Jun 30, 2026, down 44.4% from $31.65 million a year earlier.
Powered by 
Analysis
Innate Pharma (IPHA) Non-Current Assets (2017 - 2026) Analysis & Trends
As of Dec 31, 2025, Innate Pharma posted Non-Current Assets of $18.09 million, down 34.0% from the prior year.
- Non-Current Assets has declined for six consecutive years, with a five-year compound annual growth rate of -34.8% (years ended Dec 2020 to Dec 2025).
- By year, Non-Current Assets came in at $27.4 million in the year ended Dec 31, 2024 (-6.8%), $29.4 million in the year ended Dec 31, 2023 (-53.1%), $62.67 million in the year ended Dec 31, 2022 (-57.6%) and $147.85 million in the year ended Dec 31, 2021 (-3.3%).
- The figure for the quarter ended Jun 30, 2026 ranks as the lowest quarterly Non-Current Assets in data going back to the quarter ended Dec 31, 2017.
- Across the past five years, year-over-year decline in Non-Current Assets ran from 7.4% in the quarter ended Dec 31, 2021 to 59.0% in the quarter ended Dec 31, 2022.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 82.81 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 141.07 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 110.20 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 75.00 Mn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 88.47 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 61.69 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 34.86 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 159.99 Bn |
| 10 | Innate Pharma | 142.45 Mn | -64.74 Mn | - | 17.28 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 17.28 Mn |
| Dec 31, 2025 | 18.81 Mn |
| Jun 30, 2025 | 32.79 Mn |
| Dec 31, 2024 | 26.35 Mn |
| Jun 30, 2024 | 42.73 Mn |
| Dec 31, 2023 | 30.08 Mn |
| Jun 30, 2023 | 59.33 Mn |
| Dec 31, 2022 | 63.39 Mn |
| Jun 30, 2022 | 113.48 Mn |
| Dec 31, 2021 | 146.37 Mn |
| Jun 30, 2021 | 162.49 Mn |
| Dec 31, 2020 | 164.78 Mn |
| Jun 30, 2020 | 190.50 Mn |
| Dec 31, 2019 | 183.44 Mn |
| Dec 31, 2018 | 150.52 Mn |
| Dec 31, 2017 | 140.32 Mn |
API Access
Innate Pharma Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-assets&ticker=IPHA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-assets", "ticker": "IPHA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-assets&ticker=IPHA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();